VBI Vaccines Inc Contracts & Agreements
108 Contracts & Agreements
- Business Finance (37 contracts)
- Business Operations (14)
- Human Resources (13)
- Intellectual Property (1)
- Real Estate (16)
- Uncategorized (27)
- Collaboration and License Agreement, dated July 5, 2023, by and between VBI Vaccines Inc. and Brii Biosciences (Filed With SEC on November 14, 2023)
- Amended and Restated Collaboration and License Agreement, dated July 5, 2023, by and between VBI Vaccines Inc. and Brii Biosciences (Filed With SEC on November 14, 2023)
- Supply Agreement, dated July 5, 2023, by and between VBI Vaccines Inc. and Brii Biosciences (Filed With SEC on November 14, 2023)
- Letter Agreement, dated July 5, 2023, by and between VBI Vaccines Inc. and Brii Biosciences (Filed With SEC on November 14, 2023)
- Extension Agreement, dated October 27, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on November 14, 2023)
- Extension Agreement, dated November 3, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on November 14, 2023)
- Forbearance Agreement, dated November 13, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on November 14, 2023)
- Third Amendment to Loan and Guaranty Agreement, dated July 5, 2023, by and among VBI Vaccines Inc., as borrower, Variation Biotechnologies Inc., as borrower representative, each... (Filed With SEC on August 14, 2023)
- Underwriting Agreement dated July 6, 2023 between the Company and Raymond James & Associates, Inc. as Representative of the Several Underwriters (Filed With SEC on July 7, 2023)
- Form of Underwritten Warrant (Filed With SEC on July 7, 2023)
- Stock Purchase Agreement dated July 5, 2023 between the Company and Brii Biosciences Limited (Filed With SEC on July 5, 2023)
- Eighth Amendment to the Collaborative Research Agreement, signed April 17, 2023, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on May 15, 2023)
- Employment Agreement, dated April 3, 2023, by and between VBI Vaccines (Delaware) Inc. and Nell Beattie (Filed With SEC on April 4, 2023)
- Amendment to Funding Agreement, by and between Variation Biotechnologies Inc., a Canadian federal corporation and a wholly-owned subsidiary of VBI Vaccines Inc., and the Coalition... (Filed With SEC on March 13, 2023)
- Amendment to Consulting Agreement with F. Diaz-Mitoma Professional Corporation, effective January 1, 2023 (Filed With SEC on March 13, 2023)
- Amended and Restated License Agreement, dated October 18, 2022, by and among Ferring International Center S.A., SciVac Ltd. and VBI Vaccines Inc (Filed With SEC on March 13, 2023)
- Seventh Amendment to the Collaborative Research Agreement, signed February 28, 2023, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on March 13, 2023)
- Open Market Sale AgreementSM, dated August 26, 2022, by and between VBI Vaccines, Inc. and Jefferies LLC (Filed With SEC on November 10, 2022)
- Second Amendment to Loan and Guaranty Agreement, dated as of September 14, 2022, by and among VBI Vaccines Inc., as borrower, Variation Biotechnologies Inc., as borrower... (Filed With SEC on September 15, 2022)
- Press Release dated September 15, 2022 (Filed With SEC on September 15, 2022)
- Amendment to Consulting Agreement with F. Diaz-Mitoma Professional Corporation, effective December 16, 2021 (Filed With SEC on May 9, 2022)
- Sixth Amendment to the Collaborative Research Agreement, signed April 28, 2022, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on May 9, 2022)
- Amendment to the Contribution Agreement, signed March 28, 2022, by and among VBI Vaccines, Inc., Variation Biotechnologies, Inc. and Her Majesty The Queen in Right of Canada as... (Filed With SEC on May 9, 2022)
- 2016 VBI Vaccines Equity Incentive Plan, amended and restated (Filed With SEC on March 7, 2022)
- Collaborative Research Agreement, dated March 30, 2020, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on March 7, 2022)
- First Amendment to the Collaborative Research Agreement, dated December 21, 2020, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on March 7, 2022)
- Second Amendment to the Collaborative Research Agreement, dated July 8, 2021, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on March 7, 2022)
- Third Amendment to the Collaborative Research Agreement, dated August 27, 2021, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on March 7, 2022)
- Fourth Amendment to the Collaborative Research Agreement, signed November 15, 2021, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on March 7, 2022)
- Fifth Amendment Five to the Collaborative Research Agreement, signed February 8, 2022, between National Research Council of Canada and Variation Biotechnologies Inc (Filed With SEC on March 7, 2022)
- Funding Agreement, by and between Variation Biotechnologies Inc., a Canadian federal corporation and a wholly-owned subsidiary of VBI Vaccines Inc., and the Coalition for Epidemic... (Filed With SEC on March 7, 2022)
- Second Amendment to the Collaboration and License Agreement with Brii Bioscience, dated December 20, 2021 (Filed With SEC on March 7, 2022)
- Amendment to Consulting Agreement with F.Diaz-Mitoma Professional Corporation, effective January 1, 2022 (Filed With SEC on March 7, 2022)
- Unprotected Lease Agreement signed by Africa Israel Properties Ltd, Ayalot Investments (Ramat Vered) 1994 Ltd, Sharda Ltd and SciGen (IL) Ltd effective June 16, 2006 (Filed With SEC on November 8, 2021)
- Addendum of Unprotected Lease Agreement dated June 16, 2006 right of use in floor protected space signed by Africa Israel Properties Ltd, Ayalot Investments (Ramat Vered) 1994... (Filed With SEC on November 8, 2021)
- Addendum of Unprotected Lease Agreement dated June 16, 2006 signed by Africa Israel Properties Ltd, Ayalot Investments (Ramat Vered) 1994 Ltd, Sharda Ltd and SciGen (IL) Ltd... (Filed With SEC on November 8, 2021)
- Addendum of Unprotected Lease Agreement dated June 16, 2006 signed by Africa Israel Properties Ltd, Ayalot Investments (Ramat Vered) 1994 Ltd, Sharda Ltd and SciVac Ltd Company No... (Filed With SEC on November 8, 2021)
- Addendum of Unprotected Lease Agreement dated June 16, 2006 signed by Africa Israel Properties Ltd, Ayalot Investments (Ramat Vered) 1994 Ltd, Sharda Ltd and SciVac Ltd. Company... (Filed With SEC on November 8, 2021)
- Addendum to Lease Agreement for Fixed Term Rented Property dated June 16, 2006 signed by Ayalot Investment (Ramat Vered) 1994 Ltd. Private Company ###-###-#### and SciVac Ltd.... (Filed With SEC on November 8, 2021)
- Amendment to the Agreement signed by NRC on March 30, 2020 and Amendment One signed by NRC on December 31, 2020 and Amendment Two signed July 8, 2021 effective August 27, 2021 (Filed With SEC on November 8, 2021)
- Open Market Sale Agreement, dated September 3, 2021, by and between VBI Vaccines Inc. and Jefferies LLC (Filed With SEC on September 3, 2021)
- Amendment to the Agreement signed by NRC on March 30, 2020 and Amendment One signed by NRC on December 21, 2020 effective July 8, 2021 (Filed With SEC on August 2, 2021)
- Addendum #3 to sublease agreement signed by Ayalot Investment (Ramat Vered) 1994 Ltd; EMI Car Wash Systems Ltd and SciVac Ltd effective July 11, 2021 (Filed With SEC on August 2, 2021)
- Sublease signed by EMI Car Wash Systems Ltd. And SciVac Ltd effective July 11, 2021 (Filed With SEC on August 2, 2021)
- First Amendment to Loan and Guaranty Agreement, dated as of May 17, 2021, by and among VBI Vaccines Inc., as borrower, Variation Biotechnologies Inc., as borrower representative,... (Filed With SEC on May 21, 2021)
- Form of Amended and Restated Warrant (Filed With SEC on May 21, 2021)
- Amendment to Consulting Agreement with F. Diaz-Mitoma Professional Corporation, effective July 1, 2020 (Filed With SEC on May 10, 2021)
- Funding Agreement, by and between Variation Biotechnologies Inc., a Canadian federal corporation and a wholly-owned subsidiary of VBI Vaccines Inc., and the Coalition for Epidemic... (Filed With SEC on May 10, 2021)
- Amendment to the Collaboration and License Agreement with Brii Bioscience, effective April 8, 2021 (Filed With SEC on May 10, 2021)
- Description of Securities (Filed With SEC on March 2, 2021)
- Amendment to Consulting Agreement with F. Diaz-Mitoma Professional Corporation, effective January 1, 2021 (Filed With SEC on March 2, 2021)
- Amendment One to Collaborative Research Agreement between National Research Council of Canada and Variation Biotechnologies Inc. effective December 21, 2020 (Filed With SEC on March 2, 2021)
- Assignment Agreement, dated February 14, 2012, between FDS Pharma LLP and SciGen Ltd (Filed With SEC on March 2, 2021)
- Assignment Agreement, dated October 16, 2012, by and among FDS Pharma LLP, SciGen Ltd., and SciGen (I.L.) Ltd (Filed With SEC on March 2, 2021)
- Amendment to the Assignment Agreement, dated February 14, 2013, by and among SciGen Ltd., SciGen (I.L.) Ltd (Filed With SEC on March 2, 2021)
- Master Commercial Services Agreement between InVentiv Commercial Services, LLC and VBI Vaccines Inc (Filed With SEC on March 2, 2021)
- Lease agreement dated September 4, 2020, between 310 Hunt Club Limited and Variation Biotechnologies Inc (Filed With SEC on November 2, 2020)
- Contribution Agreement, dated September 16, 2020, by and among VBI Vaccines, Inc., Variation Biotechnologies, Inc. and Her Majesty The Queen in Right of Canada as Represented by... (Filed With SEC on November 2, 2020)
- Loan and Guaranty Agreement, dated as of May 22, 2020, by and among VBI Vaccines Inc., as borrower, Variation Biotechnologies Inc., as borrower representative, each of the... (Filed With SEC on May 27, 2020)
- Form of Warrant (Filed With SEC on May 27, 2020)
- Collaborative Research Agreement between National Research Council of Canada and Variation Biotechnologies Inc effective March 30, 2020 (Filed With SEC on May 6, 2020)
- Seventh Amendment to lease agreement among American Twine Owner LLC and Variation Biotechnologies (US), Inc (Filed With SEC on May 6, 2020)
- Sixth Amendment to lease agreement among American Twine Limited Partnership and Variation Biotechnologies (US) Inc (Filed With SEC on May 6, 2020)
- Fifth Amendment to lease agreement among American Twine Limited Partnership and Variation Biotechnologies (US) Inc (Filed With SEC on May 6, 2020)
- Form of Warrant Agreement (Filed With SEC on April 27, 2020)
- Underwriting Agreement, dated April 22, 2020, by and among the Company and Raymond James & Associates, Inc. and Oppenheimer & Co. Inc., as representatives of the several... (Filed With SEC on April 24, 2020)
- Description of Securities (Filed With SEC on March 5, 2020)
- Amendment to Consulting Agreement with F. Diaz-Mitoma Professional Corporation, effective January 1, 2020 (Filed With SEC on March 5, 2020)
- Waiver Agreement, dated February 25, 2020, by and among Variation Biotechnologies (US), Inc., the Guarantors party thereto, and Perceptive Credit Holdings, LP (Filed With SEC on March 5, 2020)
- Lease extension and amending agreement, dated September 5, 2019, pursuant to the Sub-Sublease, dated September 1, 2014, between Iogen Corporate and the Variation Biotechnologies... (Filed With SEC on November 6, 2019)
- Underwriting Agreement, dated September 19, 2019, by and among the Company and Raymond James & Associates, Inc. and Oppenheimer & Co. Inc., as representatives of the several... (Filed With SEC on September 20, 2019)
- Collaboration and License Agreement, dated December 4, 2018, between VBI Vaccines, Inc. and Brii Biosciences Limited (Filed With SEC on February 25, 2019)
- Stock Purchase Agreement, dated December 4, 2018, between VBI Vaccines, Inc. and Brii Biosciences Limited (Filed With SEC on February 25, 2019)
- Amendment to Sublease Lease, dated January 15, 2019, by and between Green Power YE and SciVac Ltd (Filed With SEC on February 25, 2019)
- Amendment to Consulting Agreement with F. Diaz-Mitoma Professional Corporation, effective January 1, 2019 (Filed With SEC on February 25, 2019)
- Waiver Agreement, dated February 14, 2019, by and among Variation Biotechnologies (US), Inc., the Guarantors party thereto, and Perceptive Credit Holdings, LP (Filed With SEC on February 25, 2019)
- Amendment No. 3 to Amended and Restated Credit Agreement and Guaranty and Amendment to Warrant, dated January 31, 2019, by and among Variation Biotechnologies (US), Inc., the... (Filed With SEC on February 5, 2019)
- Underwriting Agreement, dated December 13, 2018, by and among the Company and BMO Capital Markets Corp., Canaccord Genuity LLC and Oppenheimer & Co., Inc., as representatives of... (Filed With SEC on December 17, 2018)
- Employment Agreement, dated August 14, 2018, by and between VBI Vaccines (Delaware) Inc. and Christopher McNulty (Filed With SEC on August 20, 2018)
- Amendment No.2 to Amended and Restated Credit Agreement and Guaranty and Amendment to Warrant, dated July 17, 2018, by and among Variation Biotechnologies (US), Inc., the... (Filed With SEC on July 19, 2018)
- Amendment to lease agreement among American Twine Limited Partnership and Variation Biotechnologies (US), Inc (Filed With SEC on May 1, 2018)
- Form of Executive Employment Agreement (Filed With SEC on February 26, 2018)
- Amendment to Consulting Agreement with F. Diaz-Mitoma Professional Corporation, dated February 19, 2018 (Filed With SEC on February 26, 2018)
- Amendment to Sublease Lease, dated January 21, 2018, by and between Green Power YE and SciVac Ltd (Filed With SEC on February 26, 2018)
- Waiver Agreement, dated February 21, 2018, by and among Variation Biotechnologies (US), Inc., the Guarantors party thereto, and Perceptive Credit Holdings, LP (Filed With SEC on February 26, 2018)
- Form of Warrant, dated October 30, 2017 (Filed With SEC on October 31, 2017)
- Underwriting Agreement, dated October 26, 2017, by and among the Company and BMO Capital Markets Corp. and Canaccord Genuity Inc., as representatives of the several Underwriters (Filed With SEC on October 27, 2017)
- Form of Subscription Agreement, between the Company and the investor parties thereto (Filed With SEC on October 27, 2017)
- Amendment to Amended and Restated Credit Agreement and Guaranty (Filed With SEC on October 2, 2017)
- WAIVERAGREEMENT (Filed With SEC on May 15, 2017)
- AMENDMENTTO CONSULTING AGREEMENT (Filed With SEC on March 30, 2017)
- VBIVaccines INC. IncentivePLAN EffectiveMay 6, 2016 Asamended June 23, 2016 (Filed With SEC on March 20, 2017)
- VBIVACCINES INC. INCENTIVESTOCK OPTION AGREEMENT UNDER THEINCENTIVE PLAN (Filed With SEC on March 20, 2017)
- VBIVaccines Inc. Boardof Directors Services Agreement (Filed With SEC on March 20, 2017)
- VBIVaccines Inc. Boardof Directors Services Agreement (Filed With SEC on March 20, 2017)
- SEPARATIONAND RELEASE AGREEMENT (Filed With SEC on March 20, 2017)
- FirstAmendment to Boardof Directors Services Agreement (Filed With SEC on March 20, 2017)
- FirstAmendment to Boardof Directors Services Agreement (Filed With SEC on March 20, 2017)
- SecondAmendment to Boardof Directors Services Agreement (Filed With SEC on March 20, 2017)
- SecondAmendment to Boardof Directors Services Agreement (Filed With SEC on March 20, 2017)
- SecondAmendment to Boardof Directors Services Agreement (Filed With SEC on March 20, 2017)
- CONSULTINGAGREEMENT (Filed With SEC on March 20, 2017)
- INTELLECTUALPROPERTY AND CONFIDENTIAL INFORMATION AGREEMENT (Filed With SEC on March 20, 2017)
- SEPARATIONAND RELEASE AGREEMENT (Filed With SEC on March 20, 2017)
- WAIVERAGREEMENT (Filed With SEC on March 20, 2017)
- IOGEN CORPORATION, (hereinafter called the Sub-sublandlord), - and - VARIATION BIOTECHNOLOGIES INC., (hereinafter called the Sub-subtenant). (Filed With SEC on March 21, 2016)
- WAIVER AGREEMENT (Filed With SEC on March 2, 2016)
- PLEDGE AND SECURITY AGREEMENT (Filed With SEC on February 26, 2016)